Longitudinal surveillance for meningitis by Acinetobacter in a large urban setting in Brazil

被引：17

作者：

Coelho-Souza, T. ^{[1
]}

Reis, J. N. ^{[2
]}

Martins, N. ^{[1
]}

Martins, I. S. ^{[3
]}

Menezes, A. O. ^{[4
]}

Reis, M. G. ^{[4
]}

Silva, N. O. ^{[5
]}

Dias, R. C. S. ^{[6
]}

Riley, L. W. ^{[7
]}

Moreira, B. M. ^{[1
]}

机构：

[1] Univ Fed Rio de Janeiro, BR-21941902 Rio De Janeiro, Brazil

[2] Univ Fed Bahia, Salvador, BA, Brazil

[3] Univ Fed Fluminense, Niteroi, RJ, Brazil

[4] Fundacao Oswaldo Cruz, Salvador, BA, Brazil

[5] Hosp Couto Maia, Salvador, BA, Brazil

[6] Univ Fed Estado Rio de Janeiro, Rio De Janeiro, Brazil

[7] Univ Calif Berkeley, Berkeley, CA 94720 USA

来源：

CLINICAL MICROBIOLOGY AND INFECTION | 2013年 / 19卷 / 05期

基金：

英国惠康基金;

关键词：

Acinetobacter baumannii; bacterial meningitis; carbapenem resistance; multilocus sequence typing; clonal complexes; STRAINS; GENES; PCR;

D O I：

10.1111/1469-0691.12145

中图分类号：

R51 [传染病];

学科分类号：

100201 [内科学];

摘要：

The study aim was to describe the emergence of carbapenem resistance and clonal complexes (CC), defined by multilocus sequence typing (MLST), in Acinetobacter baumannii in a surveillance system for meningitis. Starting in 1996 in an urban setting of Brazil, surveillance detected meningitis by Acinetobacter sp for the first time in 2002. Up to 2008, 35 isolates were saved. Carbapenem resistance emerged in 2006, reaching 70% of A.baumannii isolates in 2008, including one that was colistin resistant. A.baumannii belonged to CC113/79 (University of Oxford/Institute Pasteur schemes), CC235/162 and CC103/15. Dissemination of infections resistant to all antimicrobial agents may occur in the future.

引用

页码：E241 / E244

页数：4

共 21 条

[1]

[Anonymous], 2012, M02A11 CLSI

[2]

[Anonymous], 2012, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically

[3]

Approved Standard-Ninth

[4]

[Anonymous], 2012, PERFORMANCE STANDARD

[5]

Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii [J].

Bartual, SG ;

Seifert, H ;

Hippler, C ;

Luzon, MAD ;

Wisplinghoff, H ;

Rodríguez-Valera, F .

JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (09) :4382-4390

[6]

Molecular epidemiology and the clinical significance of Acinetobacter baumannii complex isolated from cerebrospinal fluid in neurosurgical intensive care unit patients [J].

Bayramoglu, G. ;

Kaya, S. ;

Besli, Y. ;

Cakir, E. ;

Can, G. ;

Akineden, O. ;

Aydin, F. ;

Koksal, I. .

INFECTION, 2012, 40 (02) :163-172

[7]

Plasmid-mediated carbapenem-hydrolyzing enzyme KPC-2 in an Enterobacter sp. [J].

Hossain, A ;

Ferraro, MJ ;

Pino, RM ;

Dew, RB ;

Moland, ES ;

Lockhart, TJ ;

Thomson, KS ;

Goering, RV ;

Hanson, ND .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (11) :4438-4440

[8]

Management of meningitis due to antibiotic-resistant Acinetobacter species [J].

Kim, Baek-Nam ;

Peleq, Anton Y. ;

Lodise, Thomas P. ;

Lipman, Jeffrey ;

Li, Jian ;

Nation, Roger ;

Paterson, David L. .

LANCET INFECTIOUS DISEASES, 2009, 9 (04) :245-255

[9]

Poor Clinical Outcome for Meningitis Caused by Haemophilus influenzae Serotype A Strains Containing the IS1016-bexA Deletion [J].

Lima, Josilene B. T. ;

Ribeiro, Guilherme S. ;

Cordeiro, Soraia M. ;

Gouveia, Edilane L. ;

Salgado, Katia ;

Spratt, Brian G. ;

Godoy, Daniel ;

Reis, Mitermayer G. ;

Ko, Albert I. ;

Reis, Joice N. .

JOURNAL OF INFECTIOUS DISEASES, 2010, 202 (10) :1577-1584

[10]

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance [J].

Magiorakos, A. -P. ;

Srinivasan, A. ;

Carey, R. B. ;

Carmeli, Y. ;

Falagas, M. E. ;

Giske, C. G. ;

Harbarth, S. ;

Hindler, J. F. ;

Kahlmeter, G. ;

Olsson-Liljequist, B. ;

Paterson, D. L. ;

Rice, L. B. ;

Stelling, J. ;

Struelens, M. J. ;

Vatopoulos, A. ;

Weber, J. T. ;

Monnet, D. L. .

CLINICAL MICROBIOLOGY AND INFECTION, 2012, 18 (03) :268-281

← 1 2 3 →